Pursuant to Regulation 23(9) of SEBI(LODR) Regulations,2015, we enclose the disclosure of related party transactions for the half year ended 31.03.2025
KOVAI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMCH has filed its half-yearly related party transaction disclosure with BSE as required under SEBI (LODR) Regulation 23(9). The report covers transactions for H2 FY25 (October 2024 to March 2025). Related parties include Purani Hospital Supplies, Dr. NGP Research & Educational Trust, Biomed Hitech Industries, Sakthi Sugars, Aarthi India, and the promoter-family directors (Dr. Nalla G Palaniswami, Dr. Arun N Palaniswami, Dr. Thalamani Devi Palaniswami), along with key managerial personnel. Transactions include purchase of goods/services (such as lease rent), medical treatment charges to directors, and remuneration to the MD, JMD, Executive Director, CFO and Company Secretary. All transactions were approved by the audit committee and carried out at arm's length pricing, with no outstanding opening or closing balances between the parties.
This is a routine compliance filing and does not indicate any new event. Shareholders can note that related party dealings are at arm's length and have audit committee sign-off, which is a positive governance signal. No immediate stock price impact is expected.